The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the emphasis has been on its underlying mechanisms and nucleases. In contrast, ...
Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...
As antibiotic resistance accelerates, ESKAPE pathogens reveal how hospital superbugs survive treatment, spread across ...
For the first time, a research team at the Leibniz Institute of Plant Genetics and Crop Plant Research (IPK) has succeeded in ...
Non-model crop species represent a vast and diverse component of global agriculture, forestry, and horticulture, yet they are routinely underrepresented in ...
Sidra Medicine launches Casgevy in Qatar, the first CRISPR gene therapy for sickle cell and thalassemia, offering a potential ...
Sidra Medicine, a member of Qatar Foundation, has been qualified by Vertex Pharmaceuticals as one of a of a limited number of ...
DOHA: Sidra Medicine, a member of Qatar Foundation, announced that it has been qualified by Vertex Pharmaceuticals as one of ...
Dr Thein Swee Lay's decades-long research resulted in a genetic discovery that enabled innovative treatments for ...
For years, AI drug discovery has been judged on benchmark performance. Now, a set of studies shows what happens when those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results